OUR PRODUCTS

MOBILE APPS

GENERAL INFO

MLYS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Mineralys Therapeutics (MLYS) Earnings Date & Reports

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MLYS is expected to report earnings to rise 34.18% to -105 cents per share on August 12

Mineralys Therapeutics MLYS Stock Earnings Reports

Q2'25

Est.

$-1.06

Q1'25

Beat

by $0.29

Q4'24

Missed

by $0.27

Q3'24

Missed

by $0.42

Q2'24

Missed

by $0.11

The last earnings report on May 12 showed earnings per share of -79 cents, beating the estimate of -108 cents. With 505.74K shares outstanding, the current market capitalization sits at 847.28M.

View a ticker or compare two or three

Compare

MLYS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For MLYS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MLYS showed earnings on May 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

150 North Radnor Chester Road

Phone

+1 888 378-6240

Employees

Web

https://mineralystx.com